Page 16 - 《中国药房》2025年13期
P. 16
ment of adverse drug reaction reports with interactive vi‐ 7(4):1-16.
sual exploration[J]. Sci Rep,2022,12(1):6777. [53] OBERMEYER Z,POWERS B,VOGELI C,et al. Dissec-
[39] 贾欣悦,郑媛媛. 创新联网购药智能药箱设计[J]. 科技与 ting racial bias in an algorithm used to manage the health
创新,2022(5):79-81. of populations[J]. Science,2019,366(6464):447-453.
[40] SRINIVAS M,DURGAPRASADARAO P,RAJ V N P. [54] 于兰亦,翟晓梅. 人工智能在临床实践中的创新应用和
Intelligent medicine box for medication management 伦理挑战[J]. 数字医学与健康,2024(2):108-112.
using IoT[C]//2018 2nd International Conference on In‐ [55] FINLAYSON S G,SUBBASWAMY A,SINGH K,et al.
ventive Systems and Control(ICISC). Coimbatore:IEEE, The clinician and dataset shift in artificial intelligence[J].
2018:32-34. N Engl J Med,2021,385(3):283-286.
[41] 杨秋波. 互联网医院中的智能居家服务终端应用[J]. 集 [56] WHO. Ethics and governance of artificial intelligence for
成电路应用,2024,41(3):242-243. health:guidance on large multi-modal models[EB/OL].
[42] 许伟岚,齐金玲,李喜春,等. 人工智能辅助系统对老年 [2025-03-26]. https://www. who. int/publications/i/item/
慢性病患者居家风险管理的作用[J]. 齐齐哈尔医学院学 9789240084759.
报,2021,42(11):974-976. [57] 俞鼎. “有意义的人类控制”:智能时代人机系统“共享控
[43] HEZAM I M,ALI A M,ALSHAMRANI A M,et al. Arti‐ 制”的伦理原则解析[J]. 自然辩证法研究,2024,40(2):
ficial intelligence’s impact on drug delivery in healthcare 83-88,129.
supply chain management:data,techniques,analysis,and [58] ASTUDILLO C A,LÓPEZ-CORTÉS X A,OCQUE E,
managerial implications[J]. J Big Data,2024,11(1):177. et al. Multi-label classification to predict antibiotic resis‐
[44] SHEN J W,BU F J,YE Z Q,et al. Management of drug tance from raw clinical MALDI-TOF mass spectrometry
supply chain information based on “artificial intelligence + data[J]. Sci Rep,2024,14(1):31283.
vendor managed inventory” in China:perspective based [59] Schouten D,Nicoletti G,Dille B,et al. Navigating the
on a case study[J]. Front Pharmacol,2024,15:1373642. landscape of multimodal AI in medicine:a scoping review
[45] 郭瑞,孙嫣,王江涛,等. 基于互联网信息技术构建智能 on technical challenges and clinical applications[EB/OL].
医药供应链管理新平台[J]. 中国现代应用药学,2023,40 (2024-11-06)[2025-03-26]. https://pubmed.ncbi.nlm.nih.
(24):3445-3451. gov/40482561/.
[46] GHAZVINIAN A,FENG B,FENG J W. Enhancing effi‐ [60] MALERBI F K,NAKAYAMA L F,GAYLE DYCHIAO
ciency in the healthcare sector through multi-objective op‐ R,et al. Digital education for the deployment of artificial
timization of freight cost and delivery time in the HIV intelligence in health care[J]. J Med Internet Res,2023,
drug supply chain using machine learning[J]. Systems, 25:e43333.
2025,13(2):91. [61] EGUIA H,SÁNCHEZ-BOCANEGRA C L,VINCIARELLI
[47] ALAHMARI A R,ALRABGHI K K,DIGHRIRI I M. An F,et al. Clinical decision support and natural language
overview of the current state and perspectives of phar‐ processing in medicine:systematic literature review[J]. J
macy robot and medication dispensing technology[J]. Cu‐ Med Internet Res,2024,26:e55315.
reus,2022,14(8):e28642. [62] MONTASTRUC F,STORCK W,DE CANECAUDE C,
[48] 周志伟,赵雯雯,郁文刘. 基于物联网和人工智能技术的 et al. Will artificial intelligence chatbots replace clinical
智慧化门诊药房构建[J]. 中国医疗设备,2024,39(2): pharmacologists?An exploratory study in clinical practice
95-100. [J]. Eur J Clin Pharmacol,2023,79(10):1375-1384.
[49] 曾娜,孙华君,于广军. 配液机器人在我国静脉用药调配 [63] MUNIR F,GEHRES A,WAI D,et al. Evaluation of Chat‐
中心的应用现状与展望[J]. 上海医药,2024,45(23): GPT as a tool for answering clinical questions in phar‐
14-18. macy practice[J]. J Pharm Pract,2024,37(6):1303-1310.
[50] 葛立萌,祁建平,张志康,等. 智慧静脉药物配液机器人 [64] ALBOGAMI Y,ALFAKHRI A,ALAQIL A,et al. Safety
风险屏障机制探讨[J]. 机器人外科学杂志(中英文), and quality of AI chatbots for drug-related inquiries:a
2024,5(3):484-488. real-world comparison with licensed pharmacists[J]. Digit
[51] RAJPURKAR P,CHEN E,BANERJEE O,et al. AI in Health,2024,10:20552076241253523.
health and medicine[J]. Nat Med,2022,28(1):31-38. (收稿日期:2025-04-07 修回日期:2025-06-13)
[52] 胡奥婷,胡爱群,胡韵,等. 机器学习中差分隐私的数据 (编辑:胡晓霖)
共享及发布:技术、应用和挑战[J]. 信息安全学报,2022,
· 1562 · China Pharmacy 2025 Vol. 36 No. 13 中国药房 2025年第36卷第13期